Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Total 13F shares
-
8,980,955
-
Share change
-
+360,639
-
Total reported value
-
$1,012,211,915
-
Put/Call ratio
-
19%
-
Price per share
-
$112.72
-
Number of holders
-
130
-
Value change
-
-$4,919,869
-
Number of buys
-
68
-
Number of sells
-
82
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2018
As of 31 Dec 2018,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,980,955 shares.
The largest 10 holders included
Capital Research Global Investors, BAKER BROS. ADVISORS LP, Vanguard Group Inc, HealthCor Management, L.P., STATE STREET CORP, BlackRock Inc., JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.